Ask Well: Trying to Avoid Statins
Gina Kolata answers readers’ concerns about cholesterol-lowering statin drugs. (Source: NYT Health)
Source: NYT Health - July 16, 2013 Category: Consumer Health News Authors: By GINA KOLATA Tags: Niacin Ask Well Heart Body medicine and health Statins (Cholesterol-Lowering Drugs) Featured Source Type: news
Increased Niacin (Niaspan) Use in US, CanadaIncreased Niacin (Niaspan) Use in US, Canada
Nearly 700 000 prescriptions per month were written in the US at the end of 2009, an increase of 191% from 2002. In Canada, the use of niacin increased sevenfold, with nearly 14 000 prescriptions written at the end of 2009. Heartwire (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 10, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news
Niacin use increased nearly 200% over seven-year period
Nearly 700 000 prescriptions per month were written in the US at the end of 2009, an increase of 191% from 2002. In Canada, the use of niacin increased sevenfold, with nearly 14 000 prescriptions written at the end of 2009. (Source: theHeart.org)
Source: theHeart.org - June 10, 2013 Category: Cardiology Source Type: news
HPS2-THRIVE Trial of ER Niacin/LaropiprantHPS2-THRIVE Trial of ER Niacin/Laropiprant
Will extended release niacin be a help or hindrance to adherence and tolerability factors -- when added to lipid lowering regimens? European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 24, 2013 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
Forum: Niacin and Depression?
Bellaclarke recently posted on the forum:
Hi, I've been treated for depression for 12 years with various different antidepressants. At best, they make me feel numb. Also, I experienced side effects from every single type I've taken. I've reached my breaking point and don't feel like antidepressants are the answer any more. I've recently done a significant amount of research into high doses of niacin as an alternative to traditional pills. This week I started taking 1000mg of non-flush niacin.
Has anyone on here every taken it?
What doses did you take?
Did it work?
Did you take flush or non-flush niacin?......
Source: About.com Depression - April 22, 2013 Category: Psychiatry Source Type: news
Niacin (Niaspan) adverse events in AIM-HIGH, HPS2-THRIVENiacin (Niaspan) adverse events in AIM-HIGH, HPS2-THRIVE
AIM-HIGH researchers have yet to publish a detailed post hoc analysis of adverse events related to niacin therapy, but the investigators do not believe there was a real risk of bleeding or infection observaed with the proprietary extended-release niacin in the trial. However, the HPS2-THRIVE team believes the results of AIM-HIGH support their conclusions about niacin's off-target risks. Heartwire (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 26, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news
Niacin adverse events disputed in AIM-HIGH and HPS2-THRIVE
AIM-HIGH researchers have yet to publish a detailed post hoc analysis of adverse events related to niacin therapy, but the investigators do not believe there was a real risk of bleeding or infection observed with the proprietary extended-release niacin in the trial. However, the HPS2-THRIVE team believes the results of AIM-HIGH support their conclusions about niacin's off-target risks. (Source: theHeart.org)
Source: theHeart.org - March 26, 2013 Category: Cardiology Source Type: news
Whole-Wheat Pasta versus Inulin-Infused White Pasta: Is One Better for Me?
(HealthCastle.com) I’ve been buying inulin-infused white pasta (the SmartTM pasta) for years now. I remember the day I compared the nutrition facts on the boxes and thought, wow, these products are practically identical! Both Catelli’s SmartTM pasta and whole grain pastas contain the same amount of calories, fibre (8 grams!), protein and carbohydrate per 3/4 cup dry serving. As well, they’ve both been enriched with iron and B vitamins thiamin, riboflavin, niacin and folic acid.
read more (Source: HealthCastle.com Nutrition Tips - written by Registered Dietitians)
Source: HealthCastle.com Nutrition Tips - written by Registered Dietitians - March 26, 2013 Category: Nutrition Source Type: news
Doctor-Patient: The Niacin Discussion
(MedPage Today) -- Many physicians are finding themselves fielding a barrage of patient questions about heart disease this week due to headlines coming out of the American College of Cardiology's annual meeting in San Francisco. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 15, 2013 Category: Cardiology Source Type: news
Niacin And Laropiprant Combo Shows No Benefits, Has Some Harmful Effects In Patients With Vascular Disease
A highly anticipated study evaluating a combination of the vitamin niacin with the anti-flushing agent laropiprant finds the therapy provides no benefit to and may even be harmful for patients with vascular disease, according to research presented at the American College of Cardiology's 62nd Annual Scientific Session. Detailed trial data is presented here for the first time... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 12, 2013 Category: Consumer Health News Tags: Vascular Source Type: news
Conference report: Niacin/laropripant combination (Tredaptive) associated with increased risk of bleeding and infections
Source: Reuters Health News
Area: News
Reuters Health News has reported that according to data presented at the annual American College of Cardiology scientific meeting, niacin in combination with laropripant (Tredaptive) was associated with statistically significantly higher rates of bleeding (2.5% vs 1.9%), and infections (8.0% vs 6.6%) compared to patients taking simvastatin or simvastatin/ezetimibe. They called the differences unexpected.
Additionally, patients taking Tredaptive also experienced higher rates of serious health problems that researchers said are known side effects of niacin, which included ne...
Source: NeLM - Cardiovascular Medicine - March 12, 2013 Category: Cardiology Source Type: news
Niacin Won't Help, May Harm Heart Patients: Study
Taking the B vitamin offered no benefit in lowering cardiac deaths or heart attacks, researchers say
Source: HealthDay
Related MedlinePlus Pages: B Vitamins, Cholesterol, Statins (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - March 11, 2013 Category: Consumer Health News Source Type: news
Merck's Long-Acting Niacin Drug Has Serious Side Effects
Tredaptive, Merck & Co's long-acting niacin medication aimed at elevating HDL cholesterol (good cholesterol) has unexpected serious side effects, researchers announced on Saturday. This is more evidence against using niacin therapy for heart patients. A major study (HPS2-THRIVE) found that Tredaptive, which consist of the vitamin niacin combined with anti-flushing agent laropiprant, provides no benefit and may even be hazardous for patients with vascular disease... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 11, 2013 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news
Niacin Won't Help, May Harm Heart Patients: Study
Title: Niacin Won't Help, May Harm Heart Patients: StudyCategory: Health NewsCreated: 3/9/2013 2:35:00 PMLast Editorial Review: 3/11/2013 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - March 11, 2013 Category: Cardiology Source Type: news
EMA starts risk-benefit review of nicotinic acid and related substances
Source: European Medicines Agency
Area: News
The European Medicines Agency (EMA) has started a review of nicotinic acid and its related substances acipimox and xantinol nicotinate used to treat lipid disorders.
The review follows new data from a study which found the combination of nicotinic acid and laropiprant did not reduce the risk of major vascular events, and was in fact associated with a higher frequency of non-fatal but serious side effects. As a result, the EMA recommended the suspension of medicines containing the combination of nicotinic acid and laropiprant across the EU.
As data from th...
Source: NeLM - Cardiovascular Medicine - March 11, 2013 Category: Cardiology Source Type: news
